ArticleClinicoEconomics and outcomes research : CEOR2010

Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness.

Firas Badin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.